We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AI Medical Technology’s Skin Cancer Diagnostic Tool Effective in Trial
AI Medical Technology’s Skin Cancer Diagnostic Tool Effective in Trial
Dermalyser, an artificial intelligence (AI) skin cancer diagnostic tool from Swedish start-up AI Medical Technology, diagnosed melanoma-suspected cutaneous lesions with high accuracy in a 240-patient clinical trial conducted at 37 primary care settings in Sweden.